1Pages G, Pouyssegur J. Study of MAPK signaling using knock- out mice. Methods Mol Biol, 2004, 250: 155-166.
2Yao Y, Li W, Germann UA, et al. Extracellular signal- regulated kinase 2 is necessary formesoderm differentiation. Proe Natl AcadSeiU SA, 2003, 100: 12759-12764.
4Kawano T, Horiguchi Yamada J, Iwase S, et al. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl- positive cells and ectopic expression of cyclin D1, c Myc or active MEK abrogates this effect. Anticancer Res, 2004, 24: 2705-2712.
5Li Q, Suen TC, Sun H, et al. Nickel compounds induce apoptosis in human bronchial epithelial Beas 2B cells by activation of e-Mye through ERK pathway. Toxicol Appl Pharmacol, 2009, 235:191-198.
6Boucher MJ, Morisset J, Vachon PH, et al. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem, 2000, 79: 355-369.
7Yoon H, Min JK, Lee JW, et al. Acquisition of chemore sistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)l/2. Biochem Biophys Res Commun, 2011, 405: 333-337.
8Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell BioI, 2007, 19: 142-149.
9Borsello T, Forloni G. JNK signaling: a possible target to prevent neurodegeneration. Curr Phaml Des, 2007, 13: 1875-1886.
10Dhanasekaran DN, Johnson GL. MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene, 2007, 26; 3097-3099.
